SCTbio is a European global contract development and manufacturing organization for Advanced Therapy Medicinal Products (ATMPs). Founded in July 2021 as a spin-off from SOTIO, member of PPF Group, to directly address the growing demand for cell and gene therapy manufacturing, SCTbio holds over a decade of experience developing best-in-class clinical manufacturing services, development solutions and technologies transfer.

Pall corporation offers integrated end-to-end bioprocessing solutions for gene therapy, from early process development projects to commercialization. Our dedicated experts will work with you to overcome development and viral vector manufacturing obstacles to accelerate delivery of commercially viable gene therapies to patients. Our extensive portfolio of upstream, downstream, and formulation and filling technologies is suitable for manufacturing different viral vector types in adherent or suspension-based processes.  Whether that means quickly developing a process, helping you ensure regulatory compliance, or making existing processes easier and more effective, we are ready to work with you to accelerate your speed to market.

Cell Matters unleashes cell therapy productivity by turning cryopreservation into a competitive advantage, offering an integrated set of GTP/GMP services, in line with regulatory, quality and GTP/GMP requirements of cell therapy industry:

• Cryopreservation of leukopaks (leukapheresis) in our EU and in US platforms creating a cross-Atlantic regulatory bridge
• Development of CRYO-solutions for CRYO-sensitive cells maximizing batch size
• Integrated access to worldwide storage and distribution network via our strategic partnership

Cell Matters uniquely combines expertise in CRYO-biology, Cell Therapy Production and Biologistics.

Catenion is a management consulting firm devoted to helping pharmaceutical and biotech companies implement more innovative and effective strategies. What makes us unique? We focus on science-driven strategy: we answer key questions through comprehensive multidimensional assessments conducted by our team of life science PhDs. We have two decades of experience and relationships globally across the biopharmaceutical industry. We integrate Data Science in our analyses with a team of bioinformaticians, computational biologists and data engineers.

Andelyn Biosciences is a biopharmaceutical CDMO Pioneering Solutions That Turn Hope into Reality™. Capabilities span viral vector and analytical development, small to large scale adherent and suspension based GMP drug substance manufacturing up to 2000L, and finished drug product manufacturing services located in Columbus, OH USA. Having 20+ years of experience with viral vector manufacturing, Andelyn offers its clients direct access to globally recognized thought leaders with troubleshooting/characterization expertise and GMP material produced for over 75+ worldwide clinical trials. In addition to producing over 400+cGMP clinical sublots and 2000+research-grade productions, Andelyn currently provides research and tox grade plasmids with an additional offering of GMP plasmid, advanced quality systems, full regulatory support, semi-automated to automated fill stations, and supply chain vertical integration. Its state-of-the-art 185,000 sq ft clinical and commercial manufacturing facility comprises 14+ upstream production suites for customization of new programs and tech transferred programs. Andelyn offers clinical through commercial-scale capabilities that will help accelerate the development and manufacturing of innovative therapies to bring more treatments to more patients. 

Inspiring advances in bioprocessing, Repligen is a technology leader in filtration, chromatography, systems, process analytics and Protein A ligand development for bioprocessing and gene therapy. Propelled by a culture of innovation and collaboration, and with a focus on cost and process efficiencies, our people and our technologies help address critical steps in the production of therapeutics, vaccines and diagnostics worldwide. Named one of the fastest-growing biotech companies in the USA, Repligen is headquartered in Boston, MA with major manufacturing sites in Massachusetts, California, New Jersey, Sweden, and Germany.

Invetech helps cell and gene therapy developers to visualize, strategize and manage the future. With proven processes, expert insights and full-spectrum services, we swiftly accelerate life-changing therapies from clinical to commercial-scale manufacturing. With configurable technology platforms and automated production systems, we enable predictable, reproducible products of the highest quality and efficacy. Our integrated approach brings together biological scientists, engineers, designers and program managers to deliver successful market offerings to more people globally. Working in close collaboration with early-stage and mature life science companies, we are committed to advancing the next generation of vital, emerging therapies to revolutionize healthcare and precision medicine.